Dr Melissa Farnham awarded Cooper Foundation Grant
Dr Melissa Farnham has been awarded a Project Grant by the Rebecca L Cooper Foundation for her research investigating the role of the brain in the development of cardiometabolic diseases in people with obstructive sleep apnoea.
Collaboration advancing medical research: Drs Anna Waterhouse and John O’Sullivan
Collaboration is essential to advancing medical research, so HRI are delighted that Drs Anna Waterhouse and John O’Sullivan and their multiple research collaborations are featured by the Charles Perkins Centre, The University of Sydney.
Dr Mary Kavurma awarded NHMRC Grant
Dr Mary Kavurma was awarded a National Health and Medical Research Council (NHMRC) grant for her research into stimulating blood vessel growth to bypass arterial blockages caused by cardiovascular disease.
Monitoring hearts after stroke saves lives: experts
Doctors should monitor patients for three full days after a stroke to establish if they have a common but deadly heart condition, an expert group co-founded by HRI's Professor Ben Freedman urges.
HRI Director of Cardiovascular Research in the UK
HRI’s Director of Cardiovascular Research, Professor Shaun Jackson, recently travelled to the UK to hold discussions with scientific and clinical colleagues in the UK as well as members of the British Heart Foundation (BHF) about the global state of cardiovascular disease, its impact on the community, and how we can best fight it.
International collaboration to detect AF through face scans
HRI has worked on new camera technology that can detect deadly heart problems by scanning patients' faces in a GP waiting room.
HRI UK funds cutting-edge microscopes
The generosity of HRI UK supporters has enabled the purchase of two cutting-edge microscopes that will help speed our cardiovascular disease research to the next breakthrough.
HRI’s stroke medication breakthrough is featured on Channel 9 News
HRI spoke to Channel 9 News Health Reporter Gabriella Rogers about how a breakthrough anti-clotting drug is poised to enter Phase 2 clinical trials to improve the quality of life for thousands of stroke sufferers.
Heart disease research in the UK
Professor Willem Ouwehand, Professor of Experimental Haematology at the University of Cambridge and at the Sanger Institute speaks to Professor Ben Freedman, Deputy Director Research Strategy and Group Leader at HRI about the state of heart disease research in the UK and the potential for research collaborations.